Nomura Holdings
FPRX

Nomura Holdings’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Nomura Holdings’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,250
Closed -$668K – 2622
2021
Q1 		$668K Buy
+18,250
New +$455K ﹤0.01% 1251

Nomura Holdings's FPRX Position: Q2 2021 in Review

Nomura Holdings sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 18,250 shares — an estimated $668K sold.

Nomura Holdings first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $668K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • Nomura Holdings reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Nomura Holdings sold 18,250 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $668K.
  • Nomura Holdings first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
  • Nomura Holdings's Five Prime Therapeutics, Inc. position peaked at $668K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Nomura Holdings's 13F filing for Q2 2021, filed 16 Aug 2021.